2025-04-23T19:20:10-05:00 2024-12-31 990 2024-01-01 834634227 LYDIAN ACCELERATOR % Rohan Seth LYDI 6503845866 548 MARKET ST STE PMB 38841 San Francisco CA 94104 ROHAN SETH President 6503845866 2025-04-23 true 2024 2025-03-06 01:10:19Z Rohan Seth 548 MARKET ST Ste PMB 38841 San Francisco CA 94104 263800 false X WWW.LYDIANACCELERATOR.ORG X 2019 CA Our mission is to bring an end to the long tail of genetic disease 5 5 0 5 0 0 26259 21876 0 231042 241924 0 257301 263800 44400 137339 0 0 0 0 156976 150420 201376 287759 55925 -23959 4797421 4773460 0 4797421 4773460 To invest in scientific and translational research of personalized genetic treatments for children impacted by severe genetic disease. false false 286972 137339 CONTINUED A DRUG DISCOVERY PROGRAM FOR A NOVEL ALLELE SELECTIVE ANTISENSE OLIGONUCLEOTIDE MOLECULE TO KNOCKDOWN THE MUTANT KCNQ2 CAUSING DEVELOPMENT AND EPILEPTIC ENCEPHALOPATHY. 286972 true true false false false false false false false false false false false false false false false false false false false false false false false false false true false false false false false false false false false false false false false false false false false false false true 1 0 true 0 false false false false false false false false X 5 5 true false false false false false false true true false false true true true true false false false false false CA X ROHAN SETH 6503845866 548 MARKET ST San Francisco CA 94104 X ROHAN SETH President 40.00 0.00 X X 0 0 0 JENNIFER SETH Secretary 10.00 0.00 X X 0 0 0 CINNAMON CHU Treasurer 1.00 0.00 X X 0 0 0 MICHAEL CHU Board Member 0.50 0.00 X 0 0 0 ROHAN DANG Board Member 0.50 0.00 X 0 0 0 0 0 0 0 false false false 11840 10036 10036 21876 241924 241924 0 263800 0 0 241924 137339 137339 102 102 204 204 612 612 175 175 Research Supplies 146427 146427 Research Services 2900 2900 287759 286666 1093 0 2228 39172 4795193 4734288 4797421 4773460 0 0 X 4797421 4773460 4797421 4773460 4797421 4773460 -23959 0 X false false false X 404785 4972471 18723 26259 21876 5444114 404785 4972471 18723 26259 21876 5444114 5444114 6902 91 32605 231042 241924 512564 5956678 0.91400 0.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED CHILDRENS HOSPITAL CORPOR 300 Longwood Ave Boston MA 02115 042774441 501C3 134839 ASO RESEARCH Able Closet 1063 E San Carlos Ave San Carlos CA 94070 271212734 501c3 2500 Special Needs fam support PART I LINE 2 GRANTEES ARE REQUIRED TO PROVIDE REPORTS OF WORK AND RESULTS FOR EACH PART I LINE 2 MILESTONE INCLUDING SUMMARY OF RESEARCH AND BREAKDOWN OF COSTS BOTH DIRECT PART I LINE 2 AND PASSTHROUGH BIWEEKLY EMAIL OR VIDEO CONFERENCE CHECKINS ARE ALSO PART I LINE 2 HIGHLY RECOMMENDED Part VI Line 2 ROHAN SETH AND JENNIFER SETH HAVE A FAMILY RELATIONSHIP. Part VI Line 2 MICHAEL CHU AND CINNAMON CHU HAVE A FAMILY RELATIONSHIP. Part VI Line 11b FORM 990 IS REVIEWED BY ALL BOARD MEMBERS PRIOR TO FILING. Part VI Line 19 see above Part VI, Sec B, Line 12C: THE CONFLICT OF INTEREST POLICY COVERS DIRECTORS, PRINCIPAL OFFICERS, AND Part VI, Sec B, Line 12C: MEMBERS OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS, WHO HAVE A Part VI, Sec B, Line 12C: DIRECT OR INDIRECT FINANCIAL INTEREST. IN CONNECTION WITH ANY ACTUAL OR Part VI, Sec B, Line 12C: POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE Part VI, Sec B, Line 12C: EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO Part VI, Sec B, Line 12C: DISCLOSE ALL MATERIAL FACTS TO THE DIRECTORS CONSIDERING THE PROPOSED Part VI, Sec B, Line 12C: TRANSACTION OR ARRANGEMENT. AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND Part VI, Sec B, Line 12C: ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, Part VI, Sec B, Line 12C: HE/SHE SHALL LEAVE THE BOARD MEETING WHILE THE DETERMINATION OF A CONFLICT Part VI, Sec B, Line 12C: OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD MEMBERS SHALL Part VI, Sec B, Line 12C: DECIDE IF A CONFLICT OF INTEREST EXISTS. THE CHAIR OF THE BOARD SHALL, IF Part VI, Sec B, Line 12C: APPROPRIATE, APPOINT A DISINTERESTED PERSON OR GOVERNING COMMITTEE TO Part VI, Sec B, Line 12C: INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER Part VI, Sec B, Line 12C: EXERCISING DUE DILIGENCE, THE BOARD SHALL DETERMINE WHETHER THE CORPORATION Part VI, Sec B, Line 12C: CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR Part VI, Sec B, Line 12C: ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT Part VI, Sec B, Line 12C: OF INTEREST. COVERED PERSONS ARE REQUIRED TO REVIEW AND CERTIFY COMPLIANCE Part VI, Sec B, Line 12C: WITH THE POLICY ON AN ANNUAL BASIS. PART VI, SECTION C, LINE 19: THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND PART VI, SECTION C, LINE 19: FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST WHEN PART VI, SECTION C, LINE 19: REQUIRED BY FEDERAL OR STATE LAW.